The <scp>ARTIST</scp> Post‐Market Study: Evaluating a High G' Hyaluronic Acid ( <scp>HA</scp> ) Injectable for Chin Combined With Midface <scp>HA</scp> Filler Treatments

BACKGROUND: ) with high strength/firmness and enhanced HA concentration, optimized for lower face shaping has been developed. AIMS: (Restylane Lyft Lidocaine). PATIENTS/METHODS: (midface and/or nasolabial fold [NLF, piriform fossa] and/or jawline). Assessments included Global Aesthetic Improvement Scale (GAIS), subject and investigator satisfaction, and collection of adverse events (AEs). RESULTS: The GAIS responder rate ("improved," "much improved," or "very much improved") was 100% in all groups at Week 8 (primary endpoint) and Week 4 as assessed by the investigator and by subject self-assessment at Weeks 4 and 8. Overall subject and investigator satisfaction with treatment was high, and the safety profile for all product combinations was favorable, with no unexpected AEs. CONCLUSIONS: for comprehensive lower face and midface lift was safe and effective, with 100% aesthetic improvement at 8 weeks post-injection. The Shayping Technique provides standardized guidance for practitioners to perform safe injections and achieve optimal aesthetic outcomes.